ATP modulates the release of noradrenaline through two different prejunctional receptors on the adrenergic nerves of rat prostate

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 7, 2007, Pages 601-605

  Morikawa, Tsugumi ^a   Tanaka, Naoko ^a   Kubota, Yoko ^a   Mizuno, Hideya ^a   Nakamura, Kazuki ^a   Kunitomo, Masaru ^a   Shinozuka, Kazumasa ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Adenosine; ATP; Noradrenaline release; Prejunctional inhibitory receptor; Rat prostate

Indexed keywords

2 CHLOROADENOSINE; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; NORADRENALIN; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN;

ADRENERGIC NERVE; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ELECTROSTIMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; PROSTATE; RAT; STATISTICAL SIGNIFICANCE; SYMPATHETIC NERVE;

2-CHLOROADENOSINE; ADENOSINE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; MALE; NOREPINEPHRINE; PRESYNAPTIC TERMINALS; PROSTATE; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; RECEPTORS, PRESYNAPTIC; RECEPTORS, PURINERGIC P2; SURAMIN; SYMPATHETIC NERVOUS SYSTEM; THIONUCLEOTIDES; XANTHINES;

EID: 34250709427     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04627.x     Document Type: Article

References (31)

1. Burnstock G. A basis for distinguishing two types of purinergic receptor. In : Straub W, Bolis L (eds). Cell Membrane Receptors for Drugs and Hormones. A multidisciplinary approach. Raven Press, New York. 1992 107 18.
2. Dalziel HH, Westfall DP. Receptors for adenine nucleotides and nucleosides: Subclassification, distribution and molecular characterization. Pharmacol. Rev. 1994 46 : 449 66.
3. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 1998 50 : 413 92.
4. Ekas Jr. RD, Steenberg ML, Eikenburg DC, Lokhandwala MF. Presynaptic inhibition of sympathetic neurotransmission by adenosine in the rat kidney. Eur. J. Pharmacol. 1981 76 : 301 7.
5. Fredholm BB, Jonzon B, Lindgren E. Inhibition of noradrenaline release from hippocampal slices by a stable adenosine analogue. Acta Physiol. Scand. Suppl. 1983 515 : 7 10.
6. Fujiwara S, Kassell NF, Sasaki T, Yamashita M, Zuccarello M. Presynaptic inhibitory action of adenosine on neuromuscular transmission in the canine cavernous carotid artery. Stroke 1986 17 : 312 17.
7. Allgaier C, Wellmann H, Schobert A, von Kugelgen I. Cultured chick sympathetic neurons: Modulation of electrically evoked noradrenaline release by P2-purinoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 1995 352 : 17 24.
8. Fuder H, Brink A, Meincke M, Tauber U. Purinoceptor-mediated modulation by endogenous and exogenous agonists of stimulation-evoked [3H]-noradrenaline release on rat iris. Naunyn Schmiedebergs Arch. Pharmacol. 1992 345 : 417 23.
9. Koch H, von Kugelgen I, Starke K. P2-receptor-mediated inhibition of noradrenaline release in the rat pancreas. Naunyn Schmiedebergs Arch. Pharmacol. 1998 357 : 431 40.
10. Kugelgen I, Schoffel E, Starke K. Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 1989 340 : 522 32.
11. Lukacsko P, Blumberg A. Modulation of the vasoconstrictor response to adrenergic stimulation by nucleosides and nucleotides. J. Pharmacol. Exp. Ther. 1982 222 : 344 9.
12. Pinna C, Puglisi L, Burnstock G. ATP and vasoactive intestinal polypeptide relaxant responses in hamster isolated proximal urethra. Br. J. Pharmacol. 1998 124 : 1069 74.
13. Morikawa T, Shinozuka K, Kubota Y et al. Inhibitory modulation of noradrenaline release via prejunctional purinoceptors in rat prostate gland. Jpn. J. Pharmacol. Suppl. 2000 82 : 224 (Abstract).
14. Shinozuka K, Kunitomo M, Hattori K, Bjur RA, Westfall DP. Differences in purinoceptor modulation of norepinephrine release between caudal arteries of normotensive and hypertensive rats. J. Pharmacol. Exp. Ther. 1995 272 : 1193 8.
15. Preston A, Lau WA, Pennefather JN, Ventura S. Effects of adenine nucletides and nucleosides on neuromuscular transmission to the prostatic stroma of the rat. Br. J. Pharmacol. 2000 131 : 1073 80.
16. Smith AD, Cheek DJ, Buxton IL, Westfall DP. Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens. Clin. Exp. Pharmacol. Physiol. 1997 24 : 492 7.
17. King BF, Pintor J, Wang S, Ziganshin AU, Burnstock G. A novel P1 purinoceptor activation an outward K+ current in follicular oocytes of Xenopus leavis. J. Pharmacol. Exp. Ther. 1996 276 : 93 100.
18. King BF, Wildman SS, Townsend-Nicholson A, Burnstock G. Antagonism of an adenosine/ATP receptor in follicular Xenopus oocytes. J. Pharmacol. Exp. Ther. 1998 285 : 1005 11.
19. Matsuoka I, Ohkubo S, Kimura J. Adenine nucleotide-induced activation of adenosine A2B receptors expressed in Xenopus laevis oocytes: Involvement of a rapid and localized adenosine formation by ectonucleotidases. Mol. Pharmacol. 2002 61 : 606 13.
20. Mihaylova-Todorova S, Todorov LD, Westfall DP. Correlation between the release of the sympathetic neurotransmitter ATP and soluble nucleotidases from the guinea pig vas deferens. J. Pharmacol. Exp. Ther. 2001 296 : 64 70.
21. Todorov LD, Mihaylova-Todorova S, Westfall TD et al. Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 1997 387 : 76 9.
22. Cascalherira JF, Sebastiao AM. Adenosine nucleotide analogues, including gamma-phosphate-subatituted analogues, are metabolised extracellularly in innervated frog sartorius muscle. Eur. J. Pharmacol. 1992 222 : 49 59.
23. Nakata H, Yoshioka K, Kamiya T. Purinergic-receptor oligomerization: Implications for neural functions in the central nervous system. Neurotox. Res. 2004 6 : 291 7.
24. Nakata H, Yoshioka K, Kamiya T, Tsuga H, Oyanagi K. Functions of heteromeric association between adenosine and P2Y receptors. J. Mol. Neurosci. 2005 26 : 233 8.
25. Yoshioka K, Matsuda A, Nakata H. Pharmacology of a unique adenosine binding site in rat brain using a selective ligand. Clin. Exp. Pharmacol. Physiol. 2001 28 : 278 84.
26. Yoshioka K, Saitoh O, Nakata H. Heteromeric association creates a P2Y-like adenosine receptor. Proc. Natl Acad. Sci. USA 2001 98 : 7617 22.
27. Yoshioka K, Saitoh O, Nakata H. Agonist-promoted heteromeric oligomerization between adenosine A1 and P2Y1 receptors in living cells. FEBS Lett. 2002 523 : 147 51.
28. Yoshioka K, Hosoda R, Kuroda Y, Nakata H. Hetero-oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains. FEBS Lett. 2002 531 : 299 303.
29. Yoshioka K, Nakata H. ATP- and adenosine-mediated signaling in the central nervous system. Purinergic receptor complex: Generating adenine nucleotide-sensitive adenosine receptors. J. Pharmacol. Sci. 2004 94 : 88 94.
30. Suzuki T, Namba K, Tsuga H, Nakata H. Regulation of pharmacology by hetero-oligomerization between A(1) adenosine receptor and P2Y(2) receptor. Biochem. Biophys. Res. Commun. 2006 351 : 559 65.
31. Webb TE, Feolde E, Vigne P et al. The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase. Br. J. Pharmacol. 1996 119 : 1385 92.